Fulgent Genetics (FLGT) Shares Outstanding (Weighted Average) (2016 - 2025)
Fulgent Genetics' Shares Outstanding (Weighted Average) history spans 10 years, with the latest figure at $30.7 million for Q3 2025.
- For Q3 2025, Shares Outstanding (Weighted Average) rose 0.96% year-over-year to $30.7 million; the TTM value through Sep 2025 reached $30.7 million, up 0.96%, while the annual FY2022 figure was $30.1 million, 2.34% up from the prior year.
- Shares Outstanding (Weighted Average) for Q3 2025 was $30.7 million at Fulgent Genetics, roughly flat from $30.7 million in the prior quarter.
- Across five years, Shares Outstanding (Weighted Average) topped out at $30.8 million in Q1 2025 and bottomed at $28.8 million in Q1 2021.
- The 5-year median for Shares Outstanding (Weighted Average) is $30.1 million (2022), against an average of $30.0 million.
- The largest annual shift saw Shares Outstanding (Weighted Average) soared 36.16% in 2021 before it dropped 2.31% in 2023.
- A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $29.4 million in 2021, then increased by 2.34% to $30.1 million in 2022, then decreased by 0.28% to $30.0 million in 2023, then rose by 1.34% to $30.4 million in 2024, then rose by 0.96% to $30.7 million in 2025.
- Per Business Quant, the three most recent readings for FLGT's Shares Outstanding (Weighted Average) are $30.7 million (Q3 2025), $30.7 million (Q2 2025), and $30.8 million (Q1 2025).